Acadian Asset Management
ENTO

Acadian Asset Management’s Entero Therapeutics ENTO Stock Holding History

Acadian Asset Management’s Portfolio ENTO Stock Details ENTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-165
Closed -$15K – 1887
2023
Q2 		$15K Sell
165
-56
-25% -$5.09K ﹤0.01% 1666
2023
Q1 		$35K Buy
221
+101
+84% +$16K ﹤0.01% 1573
2022
Q4 		$43K Buy
+120
New +$43K ﹤0.01% 1596